Lipophilic drug transfer between liposomal and biological membranes: What does it mean for parenteral and oral drug delivery?

被引:24
|
作者
Fahr, Alfred
Van Hoogevest, Peter
Kuntsche, Judith
Leigh, Mathew L. S.
机构
[1] Univ Jena, Dept Pharmaceut Technol, D-07743 Jena, Germany
[2] Phares Drug Delivery AG, Muttenz, Switzerland
[3] Univ Basel, Inst Pharmaceut Technol, Dept Pharmaceut Sci, Basel, Switzerland
关键词
lipophilic drugs; liposome drug delivery transfer; membrane solubility; pharmacokinetics; bioavailability;
D O I
10.1080/08982100600848702
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review presents the current knowledge on the interaction of lipophilic, poorly water soluble drugs with liposomal and biological membranes. The center of attention will be on drugs having the potential to dissolve in a lipid membrane without perturbing them too much. The degree of interaction is described as solubility of a drug in phospholipid membranes and the kinetics of transfer of a lipophilic drug between membranes. Finally, the consequences of these two factors on the design of lipid-based carriers for oral, as well as parenteral use, for lipophilic drugs and lead selection of oral lipophilic drugs is described. Since liposomes serve as model-membranes for natural membranes, the assessment of lipid solubility and transfer kinetics of lipophilic drug using liposome formulations may additionally have predictive value for bioavailability and biodistribution and the pharmacokinetics of lipophilic drugs after parenteral as well as oral administration.
引用
收藏
页码:281 / 301
页数:21
相关论文
共 50 条
  • [1] Transfer of lipophilic drugs between liposomal membranes and biological interfaces: Consequences for drug delivery
    Fahr, A
    van Hoogevest, P
    May, S
    Bergstrand, N
    Leigh, MLS
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 26 (3-4) : 251 - 265
  • [2] Prolonged oral transmucosal delivery of highly lipophilic drug cannabidiol
    Itin, Constantin
    Barasch, Dinorah
    Domb, Abraham J.
    Hoffman, Amnon
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 581
  • [3] What does AlphaFold mean for drug discovery?
    Asher Mullard
    Nature Reviews Drug Discovery, 2021, 20 : 725 - 727
  • [4] Translatability: what does it mean in drug discovery?
    Tudor, Matthew
    Hermes, Jeffery
    Li, Jing
    DRUG DISCOVERY TODAY, 2016, 21 (06) : 865 - 867
  • [5] What does AlphaFold mean for drug discovery?
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (10) : 725 - 727
  • [6] Stability of liposomal formulations in physiological conditions for oral drug delivery
    Taira, MC
    Chiaramoni, NS
    Pecuch, KM
    Alonso-Romanowski, S
    DRUG DELIVERY, 2004, 11 (02) : 123 - 128
  • [7] Dendrimers: Novel carriers for oral and parenteral drug delivery.
    Duncan, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U376 - U377
  • [8] Oral drug delivery: What will the future bring?
    Florence, AT
    23RD INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, 1996 PROCEEDINGS, 1996, : 71 - 72
  • [9] Lipids, lipophilic drugs, and oral drug delivery - Some emerging concepts
    Charman, WN
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 89 (08) : 967 - 978
  • [10] Effects of cyclodextrins on drug delivery through biological membranes
    Loftsson, Thorsteinn
    Vogensen, Stine Byskov
    Brewster, Marcus E.
    Konradsdottir, Fifa
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (10) : 2532 - 2546